1
|
Trono P, Tocci A, Palermo B, Di Carlo A, D'Ambrosio L, D'Andrea D, Di Modugno F, De Nicola F, Goeman F, Corleone G, Warren S, Paolini F, Panetta M, Sperduti I, Baldari S, Visca P, Carpano S, Cappuzzo F, Russo V, Tripodo C, Zucali P, Gregorc V, Marchesi F, Nistico P. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC. J Immunother Cancer 2023; 11:e006913. [PMID: 37612043 PMCID: PMC10450042 DOI: 10.1136/jitc-2023-006913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/08/2023] [Indexed: 08/25/2023] Open
Abstract
BACKGROUND Understanding how cancer signaling pathways promote an immunosuppressive program which sustains acquired or primary resistance to immune checkpoint blockade (ICB) is a crucial step in improving immunotherapy efficacy. Among the pathways that can affect ICB response is the interferon (IFN) pathway that may be both detrimental and beneficial. The immune sensor retinoic acid-inducible gene I (RIG-I) induces IFN activation and secretion and is activated by actin cytoskeleton disturbance. The actin cytoskeleton regulatory protein hMENA, along with its isoforms, is a key signaling hub in different solid tumors, and recently its role as a regulator of transcription of genes encoding immunomodulatory secretory proteins has been proposed. When hMENA is expressed in tumor cells with low levels of the epithelial specific hMENA11a isoform, identifies non-small cell lung cancer (NSCLC) patients with poor prognosis. Aim was to identify cancer intrinsic and extrinsic pathways regulated by hMENA11a downregulation as determinants of ICB response in NSCLC. Here, we present a potential novel mechanism of ICB resistance driven by hMENA11a downregulation. METHODS Effects of hMENA11a downregulation were tested by RNA-Seq, ATAC-Seq, flow cytometry and biochemical assays. ICB-treated patient tumor tissues were profiled by Nanostring IO 360 Panel enriched with hMENA custom probes. OAK and POPLAR datasets were used to validate our discovery cohort. RESULTS Transcriptomic and biochemical analyses demonstrated that the depletion of hMENA11a induces IFN pathway activation, the production of different inflammatory mediators including IFNβ via RIG-I, sustains the increase of tumor PD-L1 levels and activates a paracrine loop between tumor cells and a unique macrophage subset favoring an epithelial-mesenchymal transition (EMT). Notably, when we translated our results in a clinical setting of NSCLC ICB-treated patients, transcriptomic analysis revealed that low expression of hMENA11a, high expression of IFN target genes and high macrophage score identify patients resistant to ICB therapy. CONCLUSIONS Collectively, these data establish a new function for the actin cytoskeleton regulator hMENA11a in modulating cancer cell intrinsic type I IFN signaling and extrinsic mechanisms that promote protumoral macrophages and favor EMT. These data highlight the role of actin cytoskeleton disturbance in activating immune suppressive pathways that may be involved in resistance to ICB in NSCLC.
Collapse
Affiliation(s)
- Paola Trono
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Institute of Biochemistry and Cell Biology, Consiglio Nazionale delle Ricerche, Rome, Italy
| | - Annalisa Tocci
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Belinda Palermo
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Anna Di Carlo
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Lorenzo D'Ambrosio
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Daniel D'Andrea
- Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
| | - Francesca Di Modugno
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | | | - Frauke Goeman
- SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Giacomo Corleone
- SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Sarah Warren
- NanoString Technologies Inc, Seattle, Washington, USA
| | - Francesca Paolini
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Mariangela Panetta
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Isabella Sperduti
- Biostatistics Unit, IRCSS Regina Elena National Cancer Institute, Rome, Italy
| | - Silvia Baldari
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Paolo Visca
- Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Silvia Carpano
- Second Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Federico Cappuzzo
- Second Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Vincenzo Russo
- Department of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
| | - Claudio Tripodo
- Department of Health Sciences, Human Pathology Section, Tumor Immunology Unit, University of Palermo, Palermo, Italy
| | - Paolo Zucali
- Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Vanesa Gregorc
- Department of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
| | - Federica Marchesi
- Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
| | - Paola Nistico
- Tumor of Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| |
Collapse
|
2
|
Matarrese P, Vona R, Ascione B, Cittadini C, Tocci A, Mileo AM. Tumor Microenvironmental Cytokines Drive NSCLC Cell Aggressiveness and Drug-Resistance via YAP-Mediated Autophagy. Cells 2023; 12:cells12071048. [PMID: 37048121 PMCID: PMC10093141 DOI: 10.3390/cells12071048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 03/27/2023] [Accepted: 03/28/2023] [Indexed: 04/03/2023] Open
Abstract
Dynamic reciprocity between cellular components of the tumor microenvironment and tumor cells occurs primarily through the interaction of soluble signals, i.e., cytokines produced by stromal cells to support cancer initiation and progression by regulating cell survival, differentiation and immune cell functionality, as well as cell migration and death. In the present study, we focused on the analysis of the functional response of non-small cell lung cancer cell lines elicited by the treatment with some crucial stromal factors which, at least in part, mimic the stimulus exerted in vivo on tumor cells by microenvironmental components. Our molecular and functional results highlight the role played by the autophagic machinery in the cellular response in terms of the invasive capacity, stemness and drug resistance of two non-small lung cancer cell lines treated with stromal cytokines, also highlighting the emerging role of the YAP pathway in the mutual and dynamic crosstalk between tumor cells and tumor microenvironment elements. The results of this study provide new insights into the YAP-mediated autophagic mechanism elicited by microenvironmental cytokines on non-small cell lung cancer cell lines and may suggest new potential strategies for future cancer therapeutic interventions.
Collapse
Affiliation(s)
- Paola Matarrese
- Oncology Unit, Center for Gender-Specific Medicine, Italian National Institute of Health, Viale Regina Elena, 299-00161 Rome, Italy
- Correspondence: (P.M.); (A.M.M.)
| | - Rosa Vona
- Oncology Unit, Center for Gender-Specific Medicine, Italian National Institute of Health, Viale Regina Elena, 299-00161 Rome, Italy
| | - Barbara Ascione
- Oncology Unit, Center for Gender-Specific Medicine, Italian National Institute of Health, Viale Regina Elena, 299-00161 Rome, Italy
| | - Camilla Cittadini
- Oncology Unit, Center for Gender-Specific Medicine, Italian National Institute of Health, Viale Regina Elena, 299-00161 Rome, Italy
| | - Annalisa Tocci
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144 Rome, Italy
| | - Anna Maria Mileo
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144 Rome, Italy
- Correspondence: (P.M.); (A.M.M.)
| |
Collapse
|
3
|
Spada S, Tocci A, Di Modugno F, Nisticò P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J Exp Clin Cancer Res 2021; 40:102. [PMID: 33731188 PMCID: PMC7972229 DOI: 10.1186/s13046-021-01908-8] [Citation(s) in RCA: 53] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Accepted: 03/09/2021] [Indexed: 12/11/2022]
Abstract
Deciphering extracellular matrix (ECM) composition and architecture may represent a novel approach to identify diagnostic and therapeutic targets in cancer. Among the ECM components, fibronectin and its fibrillary assembly represent the scaffold to build up the entire ECM structure, deeply affecting its features. Herein we focus on this extraordinary protein starting from its complex structure and defining its role in cancer as prognostic and theranostic marker.
Collapse
Affiliation(s)
- Sheila Spada
- Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA
| | - Annalisa Tocci
- Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy
| | - Francesca Di Modugno
- Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
| | - Paola Nisticò
- Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
| |
Collapse
|
4
|
Melchionna R, Trono P, Tocci A, Nisticò P. Actin Cytoskeleton and Regulation of TGFβ Signaling: Exploring Their Links. Biomolecules 2021; 11:biom11020336. [PMID: 33672325 PMCID: PMC7926735 DOI: 10.3390/biom11020336] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 02/15/2021] [Accepted: 02/20/2021] [Indexed: 12/14/2022] Open
Abstract
Human tissues, to maintain their architecture and function, respond to injuries by activating intricate biochemical and physical mechanisms that regulates intercellular communication crucial in maintaining tissue homeostasis. Coordination of the communication occurs through the activity of different actin cytoskeletal regulators, physically connected to extracellular matrix through integrins, generating a platform of biochemical and biomechanical signaling that is deregulated in cancer. Among the major pathways, a controller of cellular functions is the cytokine transforming growth factor β (TGFβ), which remains a complex and central signaling network still to be interpreted and explained in cancer progression. Here, we discuss the link between actin dynamics and TGFβ signaling with the aim of exploring their aberrant interaction in cancer.
Collapse
Affiliation(s)
- Roberta Melchionna
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, via Chianesi 53, 00144 Rome, Italy; (R.M.); (P.T.); (A.T.)
| | - Paola Trono
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, via Chianesi 53, 00144 Rome, Italy; (R.M.); (P.T.); (A.T.)
- Institute of Biochemistry and Cell Biology, National Research Council, via Ramarini 32, 00015 Monterotondo Scalo, Rome, Italy
| | - Annalisa Tocci
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, via Chianesi 53, 00144 Rome, Italy; (R.M.); (P.T.); (A.T.)
| | - Paola Nisticò
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, via Chianesi 53, 00144 Rome, Italy; (R.M.); (P.T.); (A.T.)
- Correspondence: ; Tel.: +39-0652662539
| |
Collapse
|
5
|
Luoni M, Declich P, Fava S, Marinoni P, Montalbetti L, Sangalli G, Sciuccati P, Tocci A, Tosi A. Bone Marrow Biopsy for the Staging of Non-Hodgkin's Lymphoma: Bilateral or Unilateral Trephine Biopsy? Tumori 2018; 81:410-3. [PMID: 8804465 DOI: 10.1177/030089169508100604] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Aim The occurrence of unilateral involvement in bilateral bone marrow trephine biopsies in non-Hodgkin's lymphomas (NHL) at disease onset (10-20% of cases) has been reported since the early 70s. Therefore, although these studies were based on small series, the use of bilateral bone marrow biopsies has become the rule. However, the clinical value of this procedure has never been clearly established. The aim of the present study was to ascertain the true value of bilateral bone marrow biopsy in the staging of NHL. Study Design We examined 368 cases of NHL (A-H according to the Working Formulation) (WF), without leukemic involvement of the peripheral blood, in order to evaluate: 1) the incidence of unilateral bone marrow involvement; 2) the percentage of patients who, as a result of unilateral bone marrow involvement, changed from stages I-II to stage IV; 3) assessment of response to therapy for patients with both bilateral or unilateral bone marrow involvement. Results In the A-C NHL groups of WF there was a unilateral bone marrow involvement of 8.8%. Overall, bone marrow involvement induced a change from clinical stages I-II to stage IV in 5.6% of cases, a figure which would correspond to a false negative rate of 2.8%, if unilateral bone marrow biopsy was performed. In the D-F and G, H groups of WF, unilateral involvement was 10.1% and 8.5% respectively; the change in stage from I-II to IV by unilateral bone marrow involvement respectively amounted to 1.4% and 2.8%, which correspond to respective false negative rates of 0.7% and 1.4%. Conclusions On the basis of these results and of the present therapeutic strategies, we propose: bilateral bone marrow biopsy for clinical stages I-II of all NHL; no bone marrow biopsy at disease onset for clinical stages III and IV of A to H histologic subtypes of the WF; unilateral bone marrow biopsy (A-C subtypes of the WF) or bilateral (D-H of the WF), after the regression of extramedullary localizations.
Collapse
Affiliation(s)
- M Luoni
- Hematology Day Hospital, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Ballatori E, Roila F, Ruggeri B, De Angelis V, Porzio G, Marchetti P, Basurto C, Ciccarese G, Palladino M, Porrozzi S, Fava S, Grimi E, Calcagno A, De Paoli A, Luoni M, Tocci A, Nuzzo A, Laudadio L, Di Blasio A, Sacco M, Contu A, Olmeo N, Pazzola A, Baldino G, Picece V, Nicodemo M, Cirillo M, Recaldin E, Dazzi C, Cariello A, Giovanis P, Zumaglini F, Rosati G, Manzione L, Bilancia D, Rossi A, Donati D, Maccaferri R, Malacarne P, Labianca R, Quadri A, Pessi M, Cortesi E, Martelli O, Giuliodori L, Silva R, Mari D, Massidda B, Ionta M, Alessandroni P, Baldelli A, Antimi M, Minelli M, Gridelli C, Rossi A, Passalacqua R, Quarta M, Sassi M, Pinaglia D, De Marino E, Giampaolo M, Ciancola S, Lalli A, Di Felice S, Casartelli C. Inappropriate Doses of Chemotherapy in Italian Breast Cancer Patients Enrolled in Clinical Trials. Tumori 2018; 93:540-3. [DOI: 10.1177/030089160709300604] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aims and background The dose of delivered chemotherapy is important to evaluate the appropriateness of the anticancer treatment. This aspect has been scarcely studied in Italy. About 7 years ago, the Italian Group for Antiemetic Research (IGAR) published a large controlled study on the effectiveness of different antiemetic prophylaxis in patients submitted to moderately emetogenic chemotherapy, where the prescribed chemotherapy was recorded. The aim of our study was to evaluate the incidence of undertreatment and to detect clinical and nonclinical factors able to explain its variability. Methods An observational study on the IGAR databank was performed to evaluate the incidence of undertreatment in the prescription in conditions of clinical trial, where the doses belonged to the eligibility criteria, and to analyze the importance of clinical and nonclinical factors using multifactorial logistic models. Results 317 patients receiving cyclophosphamide, methotrexate, and fluorouracil (CMF) and 224 anthracycline-based chemotherapy were considered. In the CMF-treated patients, 22.4% received full doses, whereas in 53.6% all three drugs of the schedule were down-dosed. In the anthracycline-treated group, 38.6% and 3.4% of patients submitted to chemotherapy containing epirubicin and doxorubicin, respectively, were undertreated. Logistic models showed that undertreatment in CMF-treated patients depended significantly on the geographic area and setting of chemotherapy administration. Although not significant, differences between age class and Karnofsky performance status were also detected. In the epirubicin-treated group, all these factors were significant. Conclusions The undertreatment of cancer patients is a relevant problem, because it could give, in daily clinical practice, worse results than those reported in clinical studies. Considering the setting of a clinical trial where our study was carried out, the incidence of undertreatment is surprisingly high. We do not know whether today, about 8 years after the IGAR study was carried out, the inappropriate dose of chemotherapy is still as frequent as we reported, but surely the topic deserves more attention.
Collapse
Affiliation(s)
- Enzo Ballatori
- Department of Internal Medicine and Public Health, University of L'Aquila
| | - Fausto Roila
- Medical Oncology Division, Policlinico Hospital, Perugia
| | | | | | | | | | | | | | | | | | - S. Fava
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - E. Grimi
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - A. Calcagno
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - A. De Paoli
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - M. Luoni
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - A. Tocci
- Medical Oncology Service, Legnano Hospital, Legnano (Milano)
| | - A. Nuzzo
- Medical Oncology Division, Hospital Renzetti, Lanciano (Chieti)
| | - L. Laudadio
- Medical Oncology Division, Hospital Renzetti, Lanciano (Chieti)
| | - A. Di Blasio
- Medical Oncology Division, Hospital Renzetti, Lanciano (Chieti)
| | - M. Sacco
- Medical Oncology Division, Hospital Renzetti, Lanciano (Chieti)
| | - A. Contu
- Medical Oncology Service, Sassari
| | - N. Olmeo
- Medical Oncology Service, Sassari
| | | | | | - V. Picece
- Medical Oncology Division, Negrar Hospital, Verona
| | - M. Nicodemo
- Medical Oncology Division, Negrar Hospital, Verona
| | - M. Cirillo
- Medical Oncology Division, Negrar Hospital, Verona
| | - E. Recaldin
- Medical Oncology Division, Negrar Hospital, Verona
| | - C. Dazzi
- Medical Oncology Division, Ravenna
| | | | | | | | | | | | | | - A. Rossi
- Medical Oncology Division, Potenza
| | - D. Donati
- Medical Oncology Division, Arcispedale S. Anna, Ferrara
| | - R. Maccaferri
- Medical Oncology Division, Arcispedale S. Anna, Ferrara
| | - P. Malacarne
- Medical Oncology Division, Arcispedale S. Anna, Ferrara
| | | | | | | | - E. Cortesi
- Medical Oncology Division, La Sapienza University, Rome
| | - O. Martelli
- Medical Oncology Division, La Sapienza University, Rome
| | | | - R.R. Silva
- Medical Oncology Service, Fabriano (Ancona)
| | - D. Mari
- Medical Oncology Service, Fabriano (Ancona)
| | - B. Massidda
- Medical Oncology Department, University of Cagliari, Cagliari
| | - M.T. Ionta
- Medical Oncology Department, University of Cagliari, Cagliari
| | | | | | - M. Antimi
- Medical Oncology Service, Hospital S. Eugenio, Rome
| | - M. Minelli
- Medical Oncology Service, Hospital S. Eugenio, Rome
| | - C. Gridelli
- Medical Oncology B Division, National Cancer Institute, Naples
| | - A. Rossi
- Medical Oncology B Division, National Cancer Institute, Naples
| | | | | | - M. Sassi
- Medical Oncology Service, Foligno (Perugia)
| | | | - E. De Marino
- Medical Oncology Department, Internal Medicine Division, V. Fazzi Hospital, Lecce
| | | | - S. Ciancola
- Medical Oncology Service, Anagni (Frosinone)
| | - A. Lalli
- Medical Oncology Service, Giulianova (Teramo)
| | | | | | | |
Collapse
|
7
|
Roila F, Ruggeri B, Ballatori E, Fatigoni S, Caserta C, Licitra L, Mirabile A, Ionta MT, Massidda B, Cavanna L, Palladino MA, Tocci A, Fava S, Colantonio I, Angelelli L, Ciuffreda L, Fasola G, Zerilli F. Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. Ann Oncol 2015; 26:1248-1253. [PMID: 25743855 DOI: 10.1093/annonc/mdv132] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2014] [Accepted: 02/19/2015] [Indexed: 08/08/2023] Open
Abstract
BACKGROUND A combination of aprepitant, a 5-HT3 receptor antagonist (r.a.), and dexamethasone is recommended for the prophylaxis of cisplatin-induced nausea and vomiting in the acute phase, and aprepitant + dexamethasone (A + D) in the delayed phase. The aim of this study was to verify if A + D is superior to metoclopramide plus dexamethasone (M + D) in preventing delayed emesis in cancer patients receiving the same prophylaxis for acute emesis. PATIENTS AND METHODS A randomized double-blind study comparing A + D versus M + D was completed in previously untreated cancer patients. Before chemotherapy, all patients were treated with intravenous palonosetron 0.25 mg and dexamethasone 12 mg, and oral aprepitant 125 mg. On day 2-4, patients randomly received oral dexamethasone 8 mg plus aprepitant 80 mg once daily (days 2-3) or metoclopramide 20 mg four times daily plus dexamethasone 8 mg bid. Primary endpoint was rate of complete response (no vomiting, no rescue treatment) in day 2-5 after chemotherapy. RESULTS Due to difficulty in the accrual of patients, 303 of the 480 planned patients were enrolled, 284 were fully evaluable, 147 receiving A + D, 137 M + D. Day 1 results were similar in both arms. On day 2-5, complete response rate was not significantly different (80.3% with A + D versus 82.5% with M + D, P < 0.38, respectively), and all secondary endpoints were also similar (complete protection, total control, no vomiting, no nausea, and score of Functional Living Index-Emesis; P < 0.24). Adverse events incidence was not significantly different between the two treatments. CONCLUSIONS In cancer patients submitted to cisplatin-based chemotherapy, receiving the same antiemetic prophylaxis for acute emesis, A + D is not superior to M + D in preventing delayed emesis, and both treatments present similar toxicity. CLINICALTRIALSGOV NUMBER NCT00869310.
Collapse
Affiliation(s)
- F Roila
- Medical Oncology Division, 'S. Maria' Hospital, Terni.
| | - B Ruggeri
- Clinical Governance, ASUR Marche, Ascoli Piceno
| | - E Ballatori
- Internal Medicine and Public Health, University of L'Aquila, Spinetoli
| | - S Fatigoni
- Medical Oncology Division, 'S. Maria' Hospital, Terni
| | - C Caserta
- Medical Oncology Division, 'S. Maria' Hospital, Terni
| | - L Licitra
- Medical Oncology, National Cancer Institute, Milano
| | - A Mirabile
- Medical Oncology, National Cancer Institute, Milano
| | - M T Ionta
- Medical Oncology II, University Hospital, Cagliari
| | - B Massidda
- Medical Oncology II, University Hospital, Cagliari
| | - L Cavanna
- Medical Oncology, Piacenza Hospital, Piacenza
| | | | - A Tocci
- Medical Oncology, Azienda Ospedaliera di Legnano, Legnano
| | - S Fava
- Medical Oncology, Azienda Ospedaliera di Legnano, Legnano
| | - I Colantonio
- Medical Oncology, Santa Croce e Carle Hospital, Cuneo
| | - L Angelelli
- Medical Oncology, ASUR Marche, Ascoli Piceno
| | - L Ciuffreda
- Medical Oncology, Molinette Hospital, Torino
| | - G Fasola
- Medical Oncology, University Hospital S. Maria della Misericordia, Udine
| | - F Zerilli
- Medical Oncology, S. Antonio Abate Hospital, Trapani, Italy
| |
Collapse
|
8
|
Gopinathan H, Tocci A, Ciambra F, Frisoni D. 3.6.1 Rapid prototyping and validation of Human factors model in a Model Based Naval Systems Engineering Application. ACTA ACUST UNITED AC 2014. [DOI: 10.1002/j.2334-5837.2012.tb01348.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- H. Gopinathan
- SELEX Sistemi Integrati S.p.A.; Via Tiburtina Km 12,400 00131 Roma Italy
| | - A. Tocci
- SELEX Sistemi Integrati S.p.A.; Via Tiburtina Km 12,400 00131 Roma Italy
| | - F. Ciambra
- SELEX Sistemi Integrati S.p.A.; Via Tiburtina Km 12,400 00131 Roma Italy
| | - D. Frisoni
- SELEX Sistemi Integrati S.p.A.; Via Tiburtina Km 12,400 00131 Roma Italy
| |
Collapse
|
9
|
Fourati Ben Mustapha S, Khrouf M, Kacem Ben Rejeb K, Elloumi Chaabene H, Merdassi G, Wahbi D, Ben Meftah M, Zhioua F, Zhioua A, Azzarello A, Host T, Mikkelsen AL, Theofanakis CP, Dinopoulou V, Mavrogianni D, Partsinevelos GA, Drakakis P, Stefanidis K, Bletsa A, Loutradis D, Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Garrido N, Remohi J, Ragni G, Ubaldi FM, Herrer R, Quera M, GIL E, Serna J, Grondahl ML, Bogstad J, Agerholm IE, Lemmen JG, Bentin-Ley U, Lundstrom P, Kesmodel US, Raaschou-Jensen M, Ladelund S, Guzman L, Ortega C, Albuz FK, Gilchrist RB, Devroey P, Smitz J, De Vos M, Bielanska M, Leveille MC, Borghi E, Magli MC, Figueroa MJ, Mascaretti G, Ferraretti AP, Gianaroli L, Szlit E, Leocata Nieto F, Maggiotto G, Arenas G, Tarducci Bonfiglio N, Ahumada A, Asch R, Sciorio R, Dayoub N, Thong J, Pickering S, Ten J, Carracedo MA, Guerrero J, Rodriguez-Arnedo A, Llacer J, Bernabeu R, Tatone C, Heizenrieder T, Di Emidio G, Treffon P, Seidel T, Eichenlaub-Ritter U, Cortezzi SS, Cabral EC, Ferreira CR, Trevisan MG, Figueira RCS, Braga DPAF, Eberlin MN, Iaconelli Jr. A, Borges Jr. E, Zabala A, Pessino T, Blanco L, Rey Valzacchi G, Leocata F, Ahumada A, Vanden Meerschaut F, Heindryckx B, Qian C, Deforce D, Leybaert L, De Sutter P, De las Heras M, De Pablo JL, Navarro B, Agirregoikoa JA, Barrenetxea G, Cruz M, Perez-Cano I, Gadea B, Herrero J, Martinez M, Roldan M, Munoz M, Pellicer A, Meseguer M, Munoz M, Cruz M, Roldan M, Gadea B, Galindo N, Martinez M, Pellicer A, Meseguer M, Perez-Cano I, Scarselli F, Alviggi E, Colasante A, Minasi MG, Rubino P, Lobascio M, Ferrero S, Litwicka K, Varricchio MT, Giannini P, Piscitelli P, Franco G, Zavaglia D, Nagy ZP, Greco E, Urner F, Wirthner D, Murisier F, Mock P, Germond M, Amorocho Llanos B, Calderon G, Lopez D, Fernandez L, Nicolas M, Landeras J, Finn-Sell SL, Leandri R, Fleming TP, Macklon NS, Cheong YC, Eckert JJ, Lee JH, Jung YJ, Hwang HK, Kang A, An SJ, Jung JY, Kwon HC, Lee SJ, Palini S, Zolla L, De Stefani S, Scala V, D'Alessandro A, Polli V, Rocchi P, Tiezzi A, Pelosi E, Dusi L, Bulletti C, Fadini R, Lain M, Mignini Renzini M, Brambillasca F, Coticchio G, Merola M, Guglielmo MC, Dal Canto M, Figueira R, Setti AS, Braga DPAF, Iaconelli Jr. A, Borges Jr. E, Worrilow KC, Uzochukwu CD, Eid S, Le Gac S, Esteves TC, van Rossem F, van den Berg A, Boiani M, Kasapi E, Panagiotidis Y, Goudakou M, Papatheodorou A, Pasadaki T, Prapas N, Prapas Y, Panagiotidis Y, Kasapi E, Goudakou M, Papatheodorou A, Pasadaki T, Vanderzwalmen P, Prapas N, Prapas Y, Norasing S, Atchajaroensatit P, Tawiwong W, Thepmanee O, Saenlao S, Aojanepong J, Hunsajarupan P, Sajjachareonpong K, Punyatanasakchai P, Maneepalviratn S, Jetsawangsri U, Herrero J, Cruz M, Tejera A, Rubio I, Romero JL, Meseguer M, Nordhoff V, Schlatt S, Schuring AN, Kiesel L, Kliesch S, Azambuja R, Okada L, Lazzari V, Dorfman L, Michelon J, Badalotti M, Badalotti F, Petracco A, Schwarzer C, Esteves TC, Nordhoff V, Schlatt S, Boiani M, Versieren K, Heindryckx B, De Croo I, Lierman S, De Vos W, Van den Abbeel E, Gerris J, De Sutter P, Milacic I, Borogovac D, Veljkovic M, Arsic B, Jovic Bojovic D, Lekic D, Pavlovic D, Garalejic E, Guglielmo MC, Coticchio G, Albertini DF, Dal Canto M, Brambillasca F, Mignini Renzini M, De Ponti E, Fadini R, Sanges F, Talevi R, Capalbo A, Papini L, Mollo V, Ubaldi FM, Rienzi LF, Gualtieri R, Albuz FK, Guzman L, Orteg C, Gilchrist RB, Devroey P, De Vos M, Smitz J, Choi J, Lee H, Ku S, Kim S, Choi Y, Kim J, Moon S, Demilly E, Assou S, Moussaddykine S, Dechaud H, Hamamah S, Takisawa T, Doshida M, Hattori H, Nakamura Y, Kyoya T, Shibuya Y, Nakajo Y, Tasaka A, Toya M, Kyono K, Novo S, Penon O, Gomez R, Barrios L, Duch M, Santalo J, Esteve J, Nogues C, Plaza JA, Perez-Garcia L, Ibanez E, Chavez S, Loewke K, Behr B, Reijo Pera R, Huang S, Wang H, Soong Y, Chang C, Okimura T, Kuwayama M, Mori C, Morita M, Uchiyama K, Aono F, Kato K, Takehara Y, Kato O, Minasi M, Casciani V, Scarselli F, Rubino P, Colasante A, Arizzi L, Litwicka K, Ferrero S, Mencacci C, Piscitelli C, Giannini P, Cucinelli F, Tocci A, Nagy ZP, Greco E, Wydooghe E, Vandaele L, Dewulf J, Van den Abbeel E, De Sutter P, Van Soom A, Moon JH, Son WY, Mahfoudh A, Henderson S, Jin SG, Shalom-Paz E, Dahan M, Holzer H, Mahmoud K, Triki-Hmam C, Terras K, Zhioua F, Hfaiedh T, Ben Aribia MH, Otsubo H, Egashira A, Tanaka K, Matsuguma T, Murakami M, Murakami K, Otsuka M, Yoshioka N, Araki Y, Kuramoto T, Smit JG, Sterrenburg MD, Eijkemans MJC, Al-Inany HG, Youssef MAFM, Broekmans FJM, Willoughby K, DiPaolo L, Deys L, Lagunov A, Amin S, Faghih M, Hughes E, Karnis M, Ashkar F, King WA, Neal MS, Antonova I, Veleva L, Petkova L, Shterev A, Nogales C, Martinez E, Ariza M, Cernuda D, Gaytan M, Linan A, Guillen A, Bronet F, Cottin V, Fabian D, Allemann F, Koller A, Spira JC, Agudo D, Martinez-Burgos M, Arnanz A, Basile N, Rodriguez A, Bronet F, Cho YS, Filioli Uranio M, Ambruosi B, Paternoster MS, Totaro P, Sardanelli AM, Dell'Aquila ME, Zollner U, Hofmann T, Zollner KP, Kovacic B, Roglic P, Vlaisavljevic V, Sole M, Santalo J, Boada M, Coroleu B, Veiga A, Martiny G, Molinari M, Revelli A, Chimote NM, Chimote M, Mehta B, Chimote NN, Sheikh N, Nath N, Mukherjee A, Rakic K, Reljic M, Kovacic B, Vlaisavljevic V, Ingerslev HJ, Kirkegaard K, Hindkjaer J, Grondahl ML, Kesmodel US, Agerholm I, Kitasaka H, Fukunaga N, Nagai R, Yoshimura T, Tamura F, Kitamura K, Hasegawa N, Nakayama K, Katou M, Itoi F, Asano E, Deguchi N, Ooyama K, Hashiba Y, Asada Y, Michaeli M, Rotfarb N, Karchovsky E, Ruzov O, Atamny R, Slush K, Fainaru O, Ellenbogen A, Chekuri S, Chaisrisawatsuk T, Chen P, Pangestu M, Jansen S, Catt S, Molinari E, Racca C, Revelli A, Ryu C, Kang S, Lee J, Chung D, Roh S, Chi H, Yokota Y, Yokota M, Yokota H, Sato S, Nakagawa M, Komatsubara M, Makita M, Araki Y, Yoshimura T, Asada Y, Fukunaga N, Nagai R, Kitasaka H, Itoi F, Tamura F, Kitamura K, Hasegawa N, Katou M, Nakayama K, Asano E, Deguchi N, Oyama K, Hashiba Y, Naruse K, Kilani S, Chapman MG, Kwik M, Chapman M, Guven S, Odaci E, Yildirim O, Kart C, Unsal MA, Yulug E, Isachenko E, Maettner R, Strehler E, Isachenko V, Hancke K, Kreienberg R, Sterzik K, Coticchio G, Guglielmo MC, Dal Canto M, Albertini DF, Brambillasca F, Mignini Renzini M, Fadini R, Zheng XY, Wang LN, Liu P, Qiao J, Inoue F, Dashtizad M, Wahid H, Rosnina Y, Daliri M, Hajarian H, Akbarpour M, Abbas Mazni O, Knez K, Tomaevic T, Vrtacnik Bokal E, Zorn B, Virant Klun I, Koster M, Liebenthron J, Nicolov A, van der Ven K, van der Ven H, Montag M, Fayazi M, Salehnia M, Beigi Boroujeni M, Khansarinejad B, Deignan K, Emerson G, Mocanu E, Wang JJ, Andonov M, Linara E, Ahuja KK, Nachef S, Figueira RCS, Braga DPAF, Setti AS, Iaconelli Jr. A, Pasqualotto FF, Borges Jr. E, Pasqualotto E, Borges Jr. E, Pasqualotto FF, Chang CC, Bernal DP, Elliott TA, Shapiro DB, Toledo AA, Nagy ZP, Economou K, Davies S, Argyrou M, Doriza S, Sisi P, Moschopoulou M, Karagianni A, Mendorou C, Polidoropoulos N, Papanicopoulos C, Stefanis P, Karamalegos C, Cazlaris H, Koutsilieris M, Mastrominas M, Gotts S, Doshi A, Harper J, Serhal P, Borini A, Guzeloglu-Kayisli O, Bianchi V, Seli E, Bianchi V, Lappi M, Bonu MA, Borini A, Mizuta S, Hashimoto H, Kuroda Y, Matsumoto Y, Mizusawa Y, Ogata S, Yamada S, Kokeguchi S, Noda Y, Shiotani M, Stojkovic M, Ilic M, Markovic N, Stojkovic P, Feng G, Zhang B, Zhou H, Zhou L, Gan X, Qin X, Shu J, Wu F, Molina Botella I, Lazaro Ibanez E, Debon Aucejo A, Pertusa J, Fernandez Colom PJ, Pellicer A, Li C, Zhang Y, Cui Y, Zhao H, Liu J, Oliveira JBA, Petersen CG, Mauri AL, Massaro FC, Silva LFI, Ricci J, Cavagna M, Pontes A, Vagnini LD, Baruffi RLR, Franco Jr. JG, Massaro FC, Petersen CG, Vagnini LD, Mauri AL, Silva LFI, Felipe V, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco Jr. JG, Vilela M, Tiveron M, Lombardi C, Viglierchio MI, Marconi G, Rawe V, Wale PL, Gardner DK, Nakagawa K, Sugiyama R, Nishi Y, Kuribayashi Y, Jyuen H, Yamashiro E, Shirai A, Sugiyama R, Inoue M, Salehnia M, Hovatta O, Tohonen V, Inzunza J, Parmegiani L, Cognigni GE, Bernardi S, Ciampaglia W, Infante FE, Tabarelli de Fatis C, Pocognoli P, Arnone A, Maccarini AM, Troilo E, Filicori M, Radwan P, Polac I, Borowiecka M, Bijak M, Radwan M. POSTER VIEWING SESSION - EMBRYOLOGY. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.79] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Versieren K, Heindryckx B, Qian C, Gerris J, De Sutter P, Exposito Navarro A, Ametzazurra A, Nagore D, Crisol L, Aspichueta F, Mendoza R, Matorras R, Garcia MM, Valley JK, Swinton PS, Boscardin WJ, Lue TF, P. Rinaudo, Wu MC, Bern O, Strassburger D, Komarovsky D, Kasterstein E, Komsky A, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Tang J, Fang C, Zhang MF, Li T, Zhuang GL, Suh DS, Joo JK, Choi JR, Kim SC, JO MS, Kim KH, Lee KS, Katz-Jaffe MG, Stevens J, McCormick S, Smith R, Schoolcraft WB, Ben-Ami I, Komsky A, Strassburger D, Bern O, Komarovsky D, Kasterstein E, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Koch J, Costello M, Kilani S, Namm A, Arend A, Aunapuu M, Joo JK, Lee KS, Choi YM, Cho JD, Sipe C, Pelts EJ, Matthews JM, Sanchez SR, Brohammer RLB, Wagner Y, Liebermann J, Uhler M, Beltsos A, Chen MJ, Guu HF, Chen YF, Yih YJ, Ho JYP, Lin TY, Ho ESC, Lopes FB, Figueira RCS, Braga DPAF, Ferreira RC, Aoki T, Iaconelli A, Borges E, Van de Velde H, Cauffman G, Verloes A, De Paepe C, Sterckx J, Van Ranst H, Devroey P, Tournaye H, Liebaers I, Santos MA, Teklenburg G, Macklon NS, Van Opstal D, Schuring-Blom GH, Krijtenburg PJ, de Vreeden-Elbertse J, Fauser BC, Baart EB, Cawood S, Doshi A, Gotts S, Serhal P, Milachich T, Petkova L, Barov D, Shterev A, Esteves TC, Balbach ST, Arauzo-Bravo MJ, Pfeiffer MJ, Boiani M, Le Gac S, van Rossem F, Esteves T, Bioani M, van den Berg A, Valeri C, Pappalardo S, De Felici M, Manna C, Ryu H, Park CY, Min SH, Choi SK, Park C, Lee SH, Kim KR, Jeong H, Chi HJ, Wittemer C, Celebi C, Viville S, Luceno Maestre F, Castilla Alcala JA, Gomez-Palomares JL, Cabello Y, Hernandez J, Marqueta J, Herrero J, Vidal E, Fernandez-Shaw S, Coroleu B, McRae C, Baskind E, Sharma V, Fisher J, Boldi Cotti P, Colasante C, Perego L, De Lauretis L, Montag M, Koster M, Nikolov A, van der Ven H, Lee SG, Lee YC, Kang SM, Kang YJ, Shin YK, Jung JH, Lim JH, Dorfmann A, Carroll K, Sisson M, Geltinger M, Yap S, Iwaszko M, Hara T, Naruse K, Matsuura K, Kodama T, Sato K, Tateaki Y, Tanaka J, Minasi MG, Scarselli F, Rubino P, Casciani V, Colasante A, Lobascio M, Alviggi E, Ferrero S, Litwicka K, Iammarrone E, Cucinelli F, Giannini PG, Tocci A, Nagy ZP, Greco E, Borini A, Tarozzi N, Fiorentin D, Bonu MA, Nadalini M, Johnson J, De Santis L, Bianchi V, Casciani V, Rubino P, Minasi MG, Colasante A, Scarselli F, Lobascio AM, Arizzi L, Iammarrone E, Litwicka K, Ferrero S, Tocci A, Piscitelli C, Cucinelli F, Nagy ZP, Greco E, Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M, Lee YM, Chen HW, Wu P, Tzeng CR, Antonova I, Milachich T, Petkova L, Yunakova M, Chaveeva P, A. Shterev, Hlinka D, Dudas M, Rutarova J, Rezacova J, Lazarovska S, Aoi Y, Takahashi H, Saitou H, Takiue C, Kawakami N, Tone M, Hirata R, Terada S, Yoshioka N, Habara T, Hayashi N, Montagut J, Bonald F, Guillen N, Guitard V, Balu-Genvrin E, Crae E, Nogueira D, Silva J, Cunha M, Viana P, Teixeira da Silva JM, Oliveira C, Goncalves A, Barros N, Sousa M, Barros A, van de Werken C, Jahr H, Laven JSE, Baart EB, Gamiz Izquierdo P, De los Santos JM, Tejera A, Pellicer A, Romero JL, Galan A, Albert C, Santos MJDL, Adriaenssens T, Wathlet S, Segers I, Verheyen G, Van De Velde H, Coucke W, Devroey P, Smitz J, Paternot G, D'Hooghe TM, Debrock S, Spiessens C, Hwang HK, Kim HM, Lee JH, Jung YJ, Kang A, Kook MJ, Jung JY, An SJ, Kwon HC, Lee SJ, Somova O, Feskov A, Feskova I, Chumakova N, Zozulina O, Zhilkova YE, Binda M, Campo R, Van Kerkhoven G, Frederickx V, Serneels A, Roziers P, Vranken I, Lopes AS, Van Nuland A, Gordts S, Puttemans P, Valkenburg M, Gordts S, Rodriguez-Arnedo A, Ten J, Guerrero J, Lledo B, Carracedo MA, Ortiz JA, Llacer J, Bernabeu R, Usui K, Nakajo Y, Ota M, Hattori H, Kyoya T, Takisawa T, Kyono K, Ferrieres A, Poulain M, Loup V, Anahory T, Dechaud H, Hamamah S, Eckert J, Premkumar G, Lock F, Brooks S, Haque S, Cameron IT, Cheong Y, Fleming TP, Prados N, Ruiz M, Garcia-Ortega J, Vime P, Hernaez MJ, Crespo M, Fernandez-Sanchez M, Pellicer A, Hashimoto S, Kato N, Saeki K, Morimoto Y, Leung CON, Pang RTK, Liu WM, Lee KF, Yeung WSB, Wada T, Elliott T, Kahn J, Lowderman J, Wright G, Chang C, Bernal D, Kort H, Nagy Z, de los Santos JM, Escrich L, Grau N, Pellicer A, Romero JL, Escriba MJ, Escriba M, Grau N, Escrich L, de los Santos JM, Pellicer A, Romero JL, Tasker F, Hamoda H, Wilner H, Grace J, Khalaf Y, Miyaji S, Mizuno S, Horiuchi L, Haruki A, Fukuda A, Morimoto Y, Utsunomiya T, Kumasako Y, Ito H, Goto K, Koike M, Abe H, Sakamoto T, Kojima F, Koshika T, Muzii L, Magli MC, Gioia L, Scaravelli G, Ferraretti AP, Gianaroli L, Capoti A, Magli MC, Lappi M, Maggi E, Ferraretti AP, Gianaroli L, Scott L, Finn A, Kloos B, Davies D, Yamada M, Hamatani T, Akutsu H, Chikazawa N, Ogawa S, Okumura N, Mochimaru Y, Kuji N, Aoki D, Yoshimura Y, Umezawa A, Aprysko VP, Yakovenko SA, Seregina EA, Yutkin EV, Yelke H, Milik S, Candan ZN, Altin G, Unal S, Atayurt Z, Y. Kumtepe, Chung JT, Son WY, Zhang X, Tan SL, Ao A, Seli E, Botros L, Henson M, Roos P, Judge K, Sakkas D, group MSGMS, Feliciano M, Monahan D, Ermolovich E, Rosenwaks Z, Palermo GD, Mantikou E, van Echten-Arends J, Sikkema-Raddatz B, van der Veen F, Repping S, Mastenbroek S, Botros L, Seli E, Henson M, Roos P, Judge K, Sakkas D, Group MBS, Wells V, Thum MY, Abdalla HI, Machiya R, Akimoto S, Nobuyoshi T, Yoshii N, Hosaka T, Odawara Y, Heindryckx B, Vanden Meerschaut F, Lierman S, Qian C, O'Leary T, Gerris J, De Sutter P, Assou S, Haouzi D, Pellestor F, Monzo C, Dechaud H, De Vos J, Hamamah S, Conaghan J, Fischer E, Popwell J, Ryan I, Chenette P, Givens C, Schriock E, Herbert C, Ermolovich E, Monahan D, Neri QV, Rosenwaks Z, Palermo GD, Verheyen G, Camus M, Van de Velde H, Haentjens P, Devroey P, Mugica A, Esbert M, Molina JM, Garrido N, Pellicer A, Ballesteros A, Calderon G, Rossi ALS, Rocha AM, Alegretti JR, Hassun PA, Gomes LP, Criscuollo T, Serafini P, Motta ELA, Munoz M, Meseguer M, Cruz M, Perez-Cano I, Pellicer A, Gadea B, Martinez M, Fortuno S, Gundersen J, Garrido N, Cruz M, Garrido N, Perez-Cano I, Munoz M, Pellicer A, Martinez M, Gadea B, Selles E, Betersen J, Meseguer M, Le Meaux E, Assou S, Haouzi D, Loup V, Dechaud H, De Vos J, Hamamah S, Ouandaogo G, Assou S, Haouzi D, Ferrieres A, Anahory T, De Vos J, Hamamah S, Monzo C, Assou S, Haouzi D, Pellestor F, Dechaud H, De Vos J, S. Hamamah, Gismano E, Borini A, Cino I, Calzi F, Rabellotti E, Papaleo E, Bianchi V, De Santis L, Sunkara SK, Siozos A, Bolton V, Khalaf Y, Braude P, El-Toukhy T, Cho YS, Ambruosi B, Totaro P, Dell'Aquila ME, Gioacchini G, Bizzaro D, Giorgini E, Ferraris P, Sabbatini S, Carnevali O, Knaggs P, Chau A, Khalil S, Trew G, Lavery S, Jovanovic VP, Gomez R, Sauer CM, Shawber CJ, Outtz HH, Wang X, Sauer MV, Kitajewski J, Zimmermann RC, Mahrous E, Clarke H, Virant-Klun I, Bacer-Kermavner L, Mivsek J, Tomazevic T, Pozlep B, Zorn B, Vrtacnik-Bokal E, Dundure I, Bazarova J, Fodina V, Brikune J, Lakutins J, Jee B, Jo J, Lee J, Suh C, Kim S, Moon S, Shufaro Y, Lebovich M, Aizenman E, Simon A, Laufer N, A. Saada Reisch, Ribeiro MA, Pinto A, Gomes F, Silva Carvalho JL, Almeida H, Massaro FC, Petersen CG, Mauri AL, Silva LFI, Nicoletti APM, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco JG, Valcarcel A, Viglierchio MI, Tiveron M, Guidobono M, Inza R, Vilela M, Vilela M, Valcarcel A, Viglierchio MI, Kenny A, Lombardi C, Marconi G. Posters * Embryology (Embryo Selection). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.140] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Jiang Y, Zhao J, Hua M, Zhen X, Yan G, Hu Y, Sun H, Selvaggi L, Zannoni GF, Tagliaferri V, De Cicco S, Vellone VG, Romualdi D, Lanzone A, Guido M, Fassbender A, Vodolazkaia AV, Bossuyt XB, Kyama MK, Meuleman CM, Peeraer KP, Tomassetti CT, D'Hooghe TM, Lumini A, Nanni L, Manna C, Pappalardo S, Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A, Manna C, Crescenzi F, Farrag A, Sallam HN, Zou L, Ding G, Zhang R, Sheng J, Huang H, von Kleinsorgen C, Wilson T, Thiel-Moder U, Ebert AD, Reinfandt M, Papadopolous T, Melo AS, Rodrigues JK, Dib LA, Andrade AZ, Donabela FC, Ferriani RA, Navarro PA, Tocci A, Royo P, Lucchini C, Ramos P, Alcazar JL, Habara T, Terada S, Yoshioka N, Hayashi N, Haouzi D, Assou S, Monzo C, Anahory T, Dechaud H, De Vos J, Hamamah S, Gonzalez-Ramos R, Rojas C, Rocco J, Poch A, Sovino H, Kohen P, Munoz A, Devoto L, Aygen MA, Atakul T, Oner G, Ozgun MT, Sahin Y, Ozturk F, Li R, Qiao J, Zhylkova I, Feskov A, Feskova I, Somova O, Chumakova N, Bontekoe S, Blake D, Heineman MJ, Williams EC, Johnson NP, Motta A, Colaci D, Horton M, Faut M, Bisioli C, Kopcow L, de Zuniga I, Wiener-Megnazi Z, Khaytov M, Lahav - Baratz S, Shiloh H, Koifman M, Oslander R, Dirnfeld M, Sundqvist J, Andersson KL, Scarselli G, Gemzell-Danielsson K, Lalitkumar PGL, Tokushige N, Markham R, Crossett B, Ahn S, Nelaturi V, Khan A, Fraser IS, Van Vaerenbergh I, Fatemi HM, Blockeel C, Van Lommel L, In't Veld P, Schuit F, Kolibianakis EM, Devroey P, Bourgain C, Sugino N, Tamura I, Lee R, Maekawa R, Gelbaya T, Gordts S, D'Hooghe TN, Gergolet M, Nardo LG, Yu H, Wang H, Huang H, Lee C, Soong Y, Kremenska Y, Masliy Y, Goncharova Y, Kremenskoy M, Veselovskyy V, Zukin V, Sudoma I, Delgado-Rosas F, Gomez R, Tamarit S, Abad A, Simon C, Pellicer A, Racicot M, Dean NL, Antaki R, Menard S, Kadoch IJ, Garcia-Guzman R, Cabrera Romero L, Hernandez J, Palumbo A, Marshall E, Lowry J, Maybin JA, Collins F, Critchley HOD, Saunders PTK, Chaudhury K, Jana SK, Banerjee P, Mukherjee S, Chakravarty BN, Allegra A, Marino A, Lama A, Santoro A, Agueli C, Mazzola S, Volpes A, Delvoux B, de Graaff AA, D'Hooghe TM, Kyama CM, Dunselman GAJ, Romano A, Caccavo D, Pellegrino NM, Totaro I, Panzarino M, Nardelli C, Depalo R, Flores R, Montanana V, Monzo A, Polo P, Garcia-Gimeno T, Cabo A, Rubio JM, Pellicer A, de Graaff AA, Dunselman GAJ, Beets GL, van Lankveld JJ, Kim HY, Lee BS, Cho SH, Choi YS, Seo SK, Lee KE, Yang HI, Abubakirov A, Vacheyshvili T, Krechetova L, Ziganshina M, Demura T, Nazarenko T, Fulop I, Rucz A, Herczegh SZ, Ujvari A, Takacs SZ, Szakonyi T, Lopez - Muniz A, Zamora L, Serra O, Guix C, Lopez-Teijon M, Benadiva C, Alvarez JG, Goudakou M, Karkanaki A, Kalogeraki A, Mataliotakis I, Kalogiannidis I, Prapas I, Hosie M, Thomson KJ, Penny CB, Thomson KJ, Penny C, Hosie MJ, McKinnon B, Klaeser B, Bersinger N, Mueller MD, Horcajadas JA, Martinez-Conejero JA, Montesinos M, Morgan M, Fortuno S, Simon C, Pellicer A, Yi KW, Shin JH, Park HT, Kim T, Kim SH, Hur JY, Chan RWS, Chan YY, Ng EHY, Yeung WSB, Santulli P, Borghese B, Chopin N, Marcellin L, de Ziegler D, Chapron C, Elnashar A, Badawy A, Mosbah A, Tzioras S, Polyzos NP, Messini CI, Papanikolaou EG, Valachis A, Patavoukas E, Mauri D, Badawy A, Messinis IE, Acar N, Hirota Y, Tranguch S, Daikoku T, Burnum KE, Xie H, Kodama A, Osuga Y, Ustunel I, Friedman DB, Caprioli RM, Dey SK, Mitra A, Sahu R, Pal M, Bhattachrayya AK, Bhattachrya J, Ferrero S, Remorgida V, Rollandi GA, Biscaldi E, Cho S, Choi YS, Kim HY, Seo SK, Yang HI, Lee KE, Shin JH, Lee BS, Arena E, Morando A, Remorgida V, Ferrero S, Tomazevic T, Ban-Frangez H, Virant-Klun I, Verdenik I, Pozlep B, Vrtacnik-Bokal E, Valenzano Menada M, Biscaldi E, Remorgida V, Morotti M, Venturini PL, Rollandi GA, Ferrero S, Dimitriadis E, Salamonsen LA, Hannan N, O'Connor O, Rombauts L, Stoikos C, Mahmoudi M, Shaikh A, Mousavifar N, Rastin M, Baharara J, Tabasi N, Takemura Y, Fujimoto A, Osuga Y, Tsutsumi R, Ooi N, Yano T, Taketani Y, Karkanaki A, Goudakou M, Kalogiannidis I, Panagiotidis I, Prapas Y, Zhang D, Lv PP, Ding GL, Zhang RJ, Zou LB, Xu GF, Gao HJ, Zhu YM, Sheng JZ, Huang HF, Martinez-Conejero JA, Labarta E, Alama P, Pellicer A, Horcajadas JA, Bosch E. Posters * Endometriosis, Endometrium and Implantation. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.242] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
|
13
|
Tocci A, Lucchini C, Minasi MG, Greco E. Unilateral ovarian endometriotic cysts do not impair follicles development, oocyte and embryo quality: report on eight controlled ovarian hyperstimulations and ICSI cycles. Hum Reprod 2009; 25:288-9; author reply 289. [DOI: 10.1093/humrep/dep402] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
14
|
Tocci A, Royo P, Alcázar JL, García-Manero M. Ultrasound study of the myoendometrial border. Rev Med Univ Navarra 2009; 53:3-5. [PMID: 19994766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Abnormal thickening of the Endometrial Subendometrial Myometrium Unit (ESEMy Unit, including basal endometrium and inner myometrium) has been detected on imaging and referred to as "diffuse adenomyosis" in infertile patients with proven endometriosis. However, no robust relationship exists between enlargement of the ESEMy Unit and adenomyosis proven on hysterectomy specimen examination; moreover, if any correlation exists, it lacks histological validation in women wishing to preserve fertility. While adenomyosis effects on fertility, if any, remain elusive, thickening of the ESEMy Unit have been consistently linked to fertility impairment in both experimental and clinical models. The hypothesis tested herein is that a novel condition exists, called "ESEMy Unit disruption disease"; it is epidemiologically different from adenomyosis, diagnosable on imaging and bears a clear impact on human fertility through various mechanisms. A new wave of good quality studies may be elicited by a clear distinction between adenomyosis and the "ESEMy Unit disruption disease".
Collapse
Affiliation(s)
- A Tocci
- Reproductive Medicine, Nuova Villa Claudia Clinic, Via Flaminia Nuova 280, Rome, Italy.
| | | | | | | |
Collapse
|
15
|
De Vico Fallani F, Astolfi L, Cincotti F, Mattia D, Tocci A, Salinari S, Marciani MG, Witte H, Colosimo A, Babiloni F. Brain network analysis from high-resolution EEG recordings by the application of theoretical graph indexes. IEEE Trans Neural Syst Rehabil Eng 2009; 16:442-52. [PMID: 18990648 DOI: 10.1109/tnsre.2008.2006196] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The extraction of the salient characteristics from brain connectivity patterns is an open challenging topic since often the estimated cerebral networks have a relative large size and complex structure. Since a graph is a mathematical representation of a network, which is essentially reduced to nodes and connections between them, the use of a theoretical graph approach would extract significant information from the functional brain networks estimated through different neuroimaging techniques. The present work intends to support the development of the "brain network analysis:" a mathematical tool consisting in a body of indexes based on the graph theory able to improve the comprehension of the complex interactions within the brain. In the present work, we applied for demonstrative purpose some graph indexes to the time-varying networks estimated from a set of high-resolution EEG data in a group of healthy subjects during the performance of a motor task. The comparison with a random benchmark allowed extracting the significant properties of the estimated networks in the representative Alpha (7-12 Hz) band. Altogether, our findings aim at proving how the brain network analysis could reveal important information about the time-frequency dynamics of the functional cortical networks.
Collapse
|
16
|
Astolfi L, De Vico Fallani F, Cincotti F, Mattia D, Bianchi L, Marciani MG, Salinari S, Colosimo A, Tocci A, Soranzo R, Babiloni F. Neural Basis for Brain Responses to TV Commercials: A High-Resolution EEG Study. IEEE Trans Neural Syst Rehabil Eng 2008; 16:522-31. [DOI: 10.1109/tnsre.2008.2009784] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
17
|
Babiloni F, Astolfi L, Cincotti F, Mattia D, Tocci A, Tarantino A, Marciani M, Salinari S, Gao S, Colosimo A, De Vico Fallani F. Cortical activity and connectivity of human brain during the prisoner's dilemma: an EEG hyperscanning study. ACTA ACUST UNITED AC 2008; 2007:4953-6. [PMID: 18003118 DOI: 10.1109/iembs.2007.4353452] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A major limitation of the approaches used in most of the studies performed so far for the characterization of the brain responses during social interaction is that only one of the participating brains is measured each time. The "interaction" between cooperating, competing or communicating brains is thus not measured directly, but inferred by independent observations aggregated by cognitive models and assumptions that link behavior and neural activation. In this paper, we use the simultaneous neuroelectric recording of several subjects engaged in cooperative games (EEG hyperscanning). This EEG hyperscanning allow us to observe and model directly the neural signature of human interactions in order to understand the cerebral processes generating and generated by social cooperation or competition. We used a paradigm called Prisoner's dilemma derived from the game theory. Results collected in a population of 22 subjects suggested that the most consistently activated structure in social interaction paradigms is the medial prefrontal cortex, which is found to be active in all the conflict situations analyzed. The role of the anterior cingulated cortex (ACC) assumes a main character being a discriminant factor for the "defect" attitude of the entire population examined. This observation is compatible with the role that the Theory of Mind assigns to the ACC.
Collapse
Affiliation(s)
- F Babiloni
- Department of Human Physiology and Pharmacology, University Sapienza, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Babiloni F, Cincotti F, Mattia D, De Vico Fallani F, Tocci A, Bianchi L, Salinari S, Marciani M, Colosimo A, Astolfi L. High resolution EEG hyperscanning during a card game. ACTA ACUST UNITED AC 2008; 2007:4957-60. [PMID: 18003119 DOI: 10.1109/iembs.2007.4353453] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
In order to study the concurrent activity in subjects interacting in cooperation or competition activities, the issue of the simultaneous recording of their brain activity became mandatory. The simultaneous recording of neuroelectric activity of the brain is called "EEG hyperscanning". We would like present results obtained by EEG hyperscannings performed on a group of subjects engaged in a card game. The EEG hyperscannings have been performed with the simultaneous use of high resolution EEG devices on groups of four subjects while they were playing a card game. We estimated the concurrent activity in multiple brains of the group and we depicted the causal connections between regions of different brains. Results obtained in a study of several groups recorded by the EEG hyperscanning reveal larger activity in prefrontal and anterior cingulated cortex in different frequency bands for the player that start the game when compared to other players. EEG hyperscannings will open a different area for the study of neuroscience, in which the activity of multiple brains during social cooperation could be investigated.
Collapse
Affiliation(s)
- F Babiloni
- Department of Human Physiology and Pharmacology, University Sapienza, Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Astolfi L, Cincotti F, Mattia D, De Vico Fallani F, Tocci A, Colosimo A, Salinari S, Marciani MG, Hesse W, Witte H, Ursino M, Zavaglia M, Babiloni F. Tracking the time-varying cortical connectivity patterns by adaptive multivariate estimators. IEEE Trans Biomed Eng 2008; 55:902-13. [PMID: 18334381 DOI: 10.1109/tbme.2007.905419] [Citation(s) in RCA: 142] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The directed transfer function (DTF) and the partial directed coherence (PDC) are frequency-domain estimators that are able to describe interactions between cortical areas in terms of the concept of Granger causality. However, the classical estimation of these methods is based on the multivariate autoregressive modelling (MVAR) of time series, which requires the stationarity of the signals. In this way, transient pathways of information transfer remains hidden. The objective of this study is to test a time-varying multivariate method for the estimation of rapidly changing connectivity relationships between cortical areas of the human brain, based on DTF/PDC and on the use of adaptive MVAR modelling (AMVAR) and to apply it to a set of real high resolution EEG data. This approach will allow the observation of rapidly changing influences between the cortical areas during the execution of a task. The simulation results indicated that time-varying DTF and PDC are able to estimate correctly the imposed connectivity patterns under reasonable operative conditions of signal-to-noise ratio (SNR) ad number of trials. An SNR of five and a number of trials of at least 20 provide a good accuracy in the estimation. After testing the method by the simulation study, we provide an application to the cortical estimations obtained from high resolution EEG data recorded from a group of healthy subject during a combined foot-lips movement and present the time-varying connectivity patterns resulting from the application of both DTF and PDC. Two different cortical networks were detected with the proposed methods, one constant across the task and the other evolving during the preparation of the joint movement.
Collapse
Affiliation(s)
- L Astolfi
- Dipartimento di Informatica e Sistemistica, Universitá La Sapienza, Roma 00185, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
De Vico Fallani F, Astolfi L, Cincotti F, Mattia D, Tocci A, Capitanio S, Marciani MG, Salinari H, Hesse W, Witte H, Gao S, Colosimo A, Babiloni F. Features extraction from time-varying cortical networks adopting a theoretical graph approach. Annu Int Conf IEEE Eng Med Biol Soc 2007; 2007:5198-5201. [PMID: 18003179 DOI: 10.1109/iembs.2007.4353513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
In this work, a novel approach is proposed in order to capture relevant features related to the structure and organization of the functional brain networks estimated in the time-frequency domain. To achieve this, we used a cascade of computational tools able to estimate first the electrical activity of the cortical surface by using high resolution EEG techniques. Then, on the cortical signals from different regions of interests we estimated the time-varying functional connectivity patterns by means of the adaptive Partial Directed Coherence. Such time-varying connectivity estimation returns a series of causality patterns evolving during the examined task which can be summarized and interpreted with the aid of mathematical indexes based on the graph theory. The combination of all these methods is demonstrated on a set of high resolution EEG data recorded from a healthy subject performing a simple foot movement.
Collapse
Affiliation(s)
- F De Vico Fallani
- Interdepartmental Research Centre for Models and Information Analysis in Biomedical Systems, University Sapienza, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Primicerio M, De Matteis G, Montanino Oliva M, Marceca M, Alessandrini A, Caviezel P, Tocci A. [Use of the TUT (Tension-free Vaginal Tape) in the treatment of female urinary stress incontinence. Preliminary results]. Minerva Ginecol 1999; 51:355-8. [PMID: 10575904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
BACKGROUND The Tension-free Vaginal Tape (TVT) represents the most recent technique for the treatment of genuine stress urinary incontinence (GSUI). The various number of surgical procedures proposed for the treatment of GSI very often do not lead to a complete remission of this pathology. The data from the literature show how TVT is a effective procedure for the treatment of female urinary incontinence. METHODS Twenty-nine women with diagnosis of urinary incontinence underwent application of polypropilene band (TVT: tension-free vaginal tape) underneath the uretra, in order to treat this disorder. The procedure has been carried out in peripheral anesthesia. RESULTS A complete remission of the urinary incontinence was obtained in 24 patients. In the remaining cases there was an improvement of the symptoms in two patients, whereas in two patients remained a secondary detrusor instability. In one case the external iliac vein was perforated thus requiring a surgical repair. CONCLUSION The short surgical time, the feasibility of the procedure and the following short hospitalization made this technique well accepted either by the surgeons ang the patients. Moreover the possibility to carry out the procedure in peripheral anesthesia allows to have the collaboration of the patient. However this technique is not free of risks, how the serious complication we had can demonstrate.
Collapse
Affiliation(s)
- M Primicerio
- Divisione di Ostetricia e Ginecologia, Ospedale San Giovanni Evangelista Tivoli, Roma
| | | | | | | | | | | | | |
Collapse
|
22
|
Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 1998; 58:562-9. [PMID: 9458106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
In human adult hematopoiesis, the TAL-1 gene is up- and down-modulated in erythropoiesis and granulopoiesis, respectively [G. L. Condorelli et al., Blood, 86: 164-175, 19951. Here, it is shown that, in a hematopoietic progenitor cell (HPC) unilineage differentiation culture, tal-1 is induced and then expressed, in a sustained manner, in the megakaryopoietic lineage, whereas it is barely or not detected in the monocytopoietic series. We have investigated the role of enforced tal-1 expression by retroviral transfer into HPCs [erythroid burst-forming units and megakaryocytic and granulomonocytic colony-forming units (CFUs)], primitive HPCs (high proliferative potential colony-forming cells), and putative hematopoietic stem cells (HSCs), assayed as long-term culture initiating cells. TAL-1 overexpression induces an increase of erythroid burst-forming unit colony number and size and megakaryocytic CFU colony number and an inhibition of granulomonocytic CFU and granulocytic CFU (CFU-G) but not monocytic CFU colony number; conversely, TAL-1 mutants with defective heterodimerizing or DNA-binding domains do not exert these effects at a significant level. Although it does not affect long-term culture initiating cells, exogenous TAL-1 causes a significant proliferative stimulus on primary and secondary high proliferative potential colony-forming cells. In conclusion, exogenous tal-1 exerts differential and stage- and lineage-specific effects on the HPC/HSC differentiation/proliferation gene programs. Thus, it induces a stimulatory effect at the level of erythroid and megakaryocytic HPCs, while exerting a selective proliferative action on downstream erythropoiesis. Furthermore, it induces differential effects on the myeloid series: the partial blockade of CFU-G differentiation is possibly linked to the sharp down-modulation of endogenous TAL-1 expression at the level of the CFU-G-to-granulopoietic precursor differentiation step; in contrast, no significant effect is observed on monocytic CFU colony formation. Finally, the stimulatory effect on primitive HPCs but not putative stem cells suggests subtle differences in the effects exerted by tal-1 overexpression on primitive HPC/HSC subsets in adult life.
Collapse
Affiliation(s)
- M Valtieri
- Department of Hematology and Oncology, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade. Mol Cell Biol 1997; 17:2954-69. [PMID: 9111367 PMCID: PMC232147 DOI: 10.1128/mcb.17.5.2954] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
The TAL-1 gene specifies a basic helix-loop-helix domain (bHLH) transcription factor, which heterodimerizes with E2A gene family proteins. tal-1 protein is abnormally expressed in the majority of T-cell acute lymphoblastic leukemias (T-ALLs). tal-1 is expressed and plays a significant role in normal erythropoietic differentiation and maturation, while its expression in early myeloid differentiation is abruptly shut off at the level of late progenitors/early differentiated precursors (G. L. Condorelli, L. Vitelli, M. Valtieri, I. Marta, E. Montesoro, V. Lulli, R. Baer, and C. Peschle, Blood 86:164-175, 1995). We show that in late myeloid progenitors (the phenotypically normal murine 32D cell line) and early leukemic precursors (the human HL-60 promyelocytic leukemia cell line) ectopic tal-1 expression induces (i) a proliferative effect under suboptimal culture conditions (i.e., low growth factor and serum concentrations respectively), via an antiapoptotic effect in 32D cells or increased DNA synthesis in HL-60 cells, and (ii) a total or marked inhibitory effect on differentiation, respectively, on granulocyte colony-stimulating factor-induced granulopoiesis in 32D cells or retinoic acid- and vitamin D3-induced granulo- and monocytopoiesis in HL-60 cells. Furthermore, experiments with 32D temperature-sensitive p53 cells indicate that aberrant tal-1 expression at the permissive temperature does not exert a proliferative effect but causes p53-mediated apoptosis, i.e., the tal-1 proliferative effect depends on the integrity of the cell cycle checkpoints of the host cell, as observed for c-myc and other oncogenes. tal-1 mutant experiments indicate that ectopic tal-1 effects are mediated by both the DNA-binding and the heterodimerization domains, while the N-terminally truncated tal-1 variant (M3) expressed in T-ALL malignant cells mimics the effects of the wild-type protein. Altogether, our results (i) indicate proliferative and antidifferentiative effects of ectopic tal-1 expression, (ii) shed light on the underlying mechanisms (i.e., requirement for the integrity of the tal-1 bHLH domain and cell cycle checkpoints in the host cell, particularly p53), and (iii) provide new experimental models to further investigate these mechanisms.
Collapse
Affiliation(s)
- G L Condorelli
- Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5541, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Murine hematopoietic tissues contain cells which, upon injection into lethally irradiated mice, produce nodules on the surface of their spleen (colony-forming unit--spleen; CFU-S). The exact hierarchical level of the hematopoietic progenitors which give rise to CFU-S is not fully established; however, cell populations highly enriched for repopulating stem cells appear to contain a high percentage of CFU-S. The experiments reported here involved the injection of human fetal liver cells into mice, under conditions similar to those of the CFU-S test. These data demonstrate that human fetal liver cells are able to induce spleen colonies (tentatively called human CFU-S) when injected into lethally irradiated mice. The number of CFU-S was increased by prior purification of human fetal liver cells. When mice were injected with human fetal liver cells inactivated by irradiation, no human CFU-S were observed. Positive staining of cells found in spleen colonies, using monoclonal antibodies specific for various human determinants, indicated the human origin of part of them. The presence of human cells within the colonies was further confirmed by in situ hybridization using a probe specific for human DNA. A mean of 30-40% of analyzed colonies was thus shown to contain some patches of human cells. These data confirm that human hematopoietic cells are able to seed, proliferate, and differentiate in a murine microenvironment.
Collapse
Affiliation(s)
- F Rezzoug
- Transplantation and Clinical Immunology Unit, Hôpital Ed. Herriot, Lyon, France
| | | | | | | | | |
Collapse
|
25
|
Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A, Tosi A, Cassi E. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. Haematologica 1997; 82:38-42. [PMID: 9107080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND AND OBJECTIVE Hepatic toxicity directly related to the drugs administered in cyclic chemotherapy (CT), although sometimes serious, does not limit the treatment of non-Hodgkin's lymphoma (NHL). Nevertheless, reports of reactivation of viral hepatitis in NHL patients with B virus (HBV) infection are becoming more frequent. The recent observation of two cases of severe liver toxicity directly correlated to CT and a case of fatal hepatic failure due to HBV replication prompted us to evaluate the hepatic toxicity of CT in 98 consecutive B-cell NHL patients treated with relatively homogeneous cyclic CT. METHODS Acute hepatic toxicity was retrospectively evaluated in 98 consecutive B-cell NHL patients who received induction CT. HBV and HCV markers were checked at presentation. All patients were tested for ALT and bilirubin before every CT course, while tests for HBV-DNA and/or for HCV-RNA were performed with PCR only when hepatitis occurred. RESULTS At presentation 22 patients (22.4%) were positive for HBsAg, and 11 (15.9%) were positive for anti-HCV. Acute hepatitis developed in 12 (12.2%) NHL patients: 8 (out of 22) in HBsAg-positive and anti-HCV-negative patients, 3 (out of 76) in HBsAg-negative patients, and 1 (out of 11) in anti-HCV-positive patients. Hepatitis was attributed to reactivation of chronic B hepatitis in 3 patients and to drug toxicity in 3 others; hepatitis was undefined in 6 cases. INTERPRETATION AND CONCLUSIONS Drug-related liver toxicity is not a rare occurrence in NHL patients. Reactivation of HBV replication is responsible for a relevant number of the hepatitis cases observed. We did not detect acute hepatitis due to the reactivation of HCV replication (in chronic C hepatitis carriers).
Collapse
Affiliation(s)
- P Faggioli
- Sezione di Emato/Oncologia, Ospedale di Legnano, Italy
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Tocci A, Parolini I, Gabbianelli M, Testa U, Luchetti L, Samoggia P, Masella B, Russo G, Valtieri M, Peschle C. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program. Blood 1996; 88:2878-88. [PMID: 8874184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
In preliminary studies, we have analyzed the hematopoietic growth factor (HGF) requirement of hematopoietic progenitor cells (HPCs) purified from embryonic-fetal liver (FL) and grown in fetal calf serum-supplemented (FCS+) clonogenic culture. The key role of erythropoietin (Epo) for colony formation by early erythroid progenitors (burst-forming units-erythroid [BFU-E]) has been confirmed. Furthermore, in the absence of exogenous HGFs, FL monocytic progenitors (colony-forming unit monocyte [CFU-M]) generate large colonies exclusively composed of monocytes-macrophages; these colonies are absent in FCS- clonogenic culture. On this basis, we have investigated the role of all-trans retinoic acid (ATRA) and its isomer 9-cis RA in FL hematopoiesis. Both compounds modulate the growth of purified FL HPCs, which show a dose-dependent shift from mixed/erythroid/ monocytic to granulocytic colony formation. Studies on unicellular and paired daughter cell culture unequivocally indicate that the shift is mediated by modulation of the HPC differentiation program to the granulopoietic pathway (rather than RA-induced down-modulation of multipotent/ erythroid/monocytic HPC growth coupled with recruitment of granulocytic HPCs). ATRA and 9-cis RA also exert their effect on the proliferation of primitive HPCs (high-proliferative potential colony-forming cells [HPP-CFCs]) and putative hematopoietic stem cells (HSCs; assayed in Dexter-type long-term culture). High concentrations of either compound (1) drastically reduced the number of primary HPP-CFC colonies and totally abolished their recloning capacity and (2) inhibited HSC proliferation. It is crucial that these results mirror recent observations indicating that murine adult HPCs transduced with dominant negative ATRA receptor (RAR) gene are immortalized and show a selective blockade of granulocytic differentiation. Altogether, these results suggest that ATRA/9-cis RA may play a key role in FL hematopoiesis via a dual effect hypothetically mediated by interaction with the RAR/RXR heterodimer, ie, inhibition of HSC/ primitive HPC proliferation and induction of CFU-GEMM/ BFU-E/CFU-M shift from the multipotent/erythroid/monocytic to the granulocytic-neutrophilic differentiation program.
Collapse
Affiliation(s)
- A Tocci
- Department of Hematology and Oncology, Istituto Superiore di Sanità, Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Fava S, Sironi M, Cozzi L, Faggioli P, Gobbo C, Luoni M, Tocci A. Diagnostic pitfalls of echography in a case of hepatic cavernous hemangioma. Oncol Rep 1996; 3:833-4. [PMID: 21594462 DOI: 10.3892/or.3.5.833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
An ecographic study of the liver in a 55-year-old female, with a history of mastectomy for a breast ductal cancer, showed multiple focal lesions. On computer tomography, we interpreted these lesions as metastatic disease. 99m Tc-labeled RBC showed non-homogeneous flow distribution in the right lobe of the liver. Fine needle aspiration biopsy under ecographic guidance showed no metastatic disease, and suggested a vascular lesion. The presence of spindle-shaped cells, reactive for CD 34 and for factor VIII, enabled definitive diagnosis of angiomatous lesion. Cytological confirmation of each hepatic mass is a mandatory prerequisite for any therapy.
Collapse
Affiliation(s)
- S Fava
- LEGNANO GEN HOSP,DEPT PATHOL,I-20025 LEGNANO,ITALY. LEGNANO GEN HOSP,DEPT INTERNAL MED,HEMATOL ONCOL SECT,I-20025 LEGNANO,ITALY
| | | | | | | | | | | | | |
Collapse
|
28
|
Tocci A, Rezzoug F, Wahbi K, Touraine JL. Fetal liver generates low CD4 hematopoietic cells in murine stromal cultures. Blood 1995; 85:1463-71. [PMID: 7888669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
We have demonstrated that 0.2% to 11% of cells from the fetal liver (FL) reacted specifically with high concentrations of anti-CD4 monoclonal antibody (MoAb). CD4+ cells from FL were similar in surface phenotype and fluorescence characteristics to the CD4+ population found previously in adult bone marrow (BM). FL and BM cells were seeded in cultures that allow differentiation to primitive precursors. FL cells released many low CD4+ and low Thy+ cells in the supernatant, while BM cells seeded under the same conditions did not. We studied the nonadherent cells harvested from 10-day FL cultures (greater than 90% low CD4+). In methylcellulose, they were able to produce more colonies that appear to be characteristic of earlier stages in the hierarchy of hematopoietic precursors (especially erythroid bursts and colonies composed of both myeloid and erythroid elements) in comparison with CD4- cells from 10-day BM cultures. CD4+ cells harvested from FL cultures initiated secondary cultures containing both a stromal layer and large hematopoietic colonies when replated under conditions similar to those of primary cultures. Furthermore, a limited number of CD4+ cells from 10-day FL cultures were able to repopulate lethally irradiated mice. Although we cannot formally exclude the possibility that the low CD4 cells produced in FL cultures were derived exclusively from the proliferation of the few CD4 cells found in fresh FL, the dynamic analysis of the development of these cells in culture favors the generation of this important population from a CD4- subset of hematopoietic stem cells (HSCs). We speculate that FL contains a prevalent population of very primitive cells not expressing the CD4 antigen, tentatively called "pre-low CD4 precursors." These primitive cells can differentiate into low CD4+ cells that share many characteristics with pluripotent HSCs of the adult type. These data indicate the possibility of using hematopoietic progenitors obtained by the expansion/differentiation of fetal stem cells in culture for transplantation purposes.
Collapse
Affiliation(s)
- A Tocci
- Transplantation and Clinical Immunology Unit, INSERM U 80, Lyon, France
| | | | | | | |
Collapse
|
29
|
Tosi A, De Paoli A, Fava S, Luoni M, Sironi M, Tocci A, Assi A, Cassi E. Undifferentiated granulocytic sarcoma: a case with epidural onset preceding acute promyelocytic leukemia. Haematologica 1995; 80:44-6. [PMID: 7758990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
This study reports a case of granulocytic sarcoma that developed in the epidural zone 25 days before clinical evidence of an acute promyelocytic leukemia. The case presented the diagnostic difficulties that are common to all aleukemic granulocytic sarcomas. Moreover, it highlights the very rare association between granulocytic sarcoma and acute promyelocytic leukemia, which is far from being explained.
Collapse
Affiliation(s)
- A Tosi
- 2nd Medical Operative Unit, Ospedale di Legnano, Italy
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Fava S, Declich P, De Paoli A, Luoni M, Tosi A, Tocci A, Assi A, Cassi E. [Acute secondary myeloblastic leukemia in non-Hodgkin's lymphoma. A case of pericardial onset (granulocytic sarcoma) and the potential clonal remission]. Recenti Prog Med 1994; 85:585-6. [PMID: 7899683 DOI: pmid/7899683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- S Fava
- Day-Hospital di Ematologia Oncologica e Oncologia Medica, Legnano
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Fava S, De Paoli A, Grimi E, Luoni M, Tocci A, Tosi A, Cassi E. [Prolymphocytic leukemia: the therapeutic strategy]. Recenti Prog Med 1994; 85:496-501. [PMID: 7809465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Prolymphocytic leukemia (PLL) is a malignant lymphoproliferative disorder, characterized by massive splenomegaly, predominance of prolymphocytes in the peripheral blood and bone marrow, minimal lymph nodes enlargement and poor prognosis. It accounts for a 5-10% case of chronic lymphocytic leukemia (CLL). Patients age is usually over the fifth decade, the disease is 4.1 more common in males. More than 80% are B-lymphocytic derived cells showing a post-thymic phenotype. Median survival of B-PLL patients is 3 years, while only 7 months in T-PLL. Standard therapy of CLL with alkylating agents and prednisone have been not much effective in the treatment of PLL with a response rate of about 20%. Up to date no ideal treatment is available for PLL. A realistic goal is probably to achieve a clinical course transformation, from aggressive to mild, thus changing from short to long term prognosis. For this purpose the initial therapeutic approach cannot be limited to a single agent only. Splenic irradiation, intensive anthracyclines-based regimens, leukapheresis combine together represent the best therapeutic choice. Alkylating agents with or without prednisone may play a role in keeping indolent clinical course. Fludarabine has shown antileukemic activity against PPL even in patients resistant.
Collapse
Affiliation(s)
- S Fava
- Day-Hospital di Ematologia Oncologica e Oncologia Medica, Medicina 2a, Ospedale, Legnano
| | | | | | | | | | | | | |
Collapse
|
32
|
Tocci A, Menichella G, Perretta G, Pierelli L, Noia G, Mancuso S. Fetal tissue collection from spontaneous abortions: a report from a single centre. Fetal Diagn Ther 1994; 9:204-8. [PMID: 7914729 DOI: 10.1159/000263932] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Due to immunological immaturity, the fetus is the ideal recipient as well as donor of haemopoietic stem cells (HSCs); thus intrauterine therapy may prove to be effective in all major haemopoietic disorders when early prenatal diagnosis is available. In man, "fetus-to-fetus" transplantation has demonstrated the possibility of grafting donor HSCs and reconstituting immunodeficient fetuses. The limitations of fetal tissue use for transplantation derive from the origin of tissues from elective abortions. Early and late live spontaneous abortions may constitute an alternative to elective abortions, but are widely considered as unsuitable for fetal tissue collection because of rapid loss of viability and/or infections. The aim of this retrospective study was to assess the number of live abortions in a population of women who underwent spontaneous abortion in a single centre. In a 19-month period, 9 spontaneous abortions alive at the moment of delivery and 8 with a heart beat at the last ultrasound scan before abortion were recorded. In 1 case, fetal liver (FL) harvesting was easily performed and the tissue was cryopreserved, subsequently thawed and injected into a monkey fetus. This case shows the feasibility of this approach. The majority of cases reviewed consisted of late abortions. These findings clearly show that fetal tissue collection from spontaneous abortions is feasible for research purposes, for postnatal FL transplantation and for intrauterine transplantation, postnatal FL transplantation and for intrauterine transplantation, provided that depletion of more mature cells is performed when FL of later gestational age are used.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- A Tocci
- Istituto di Ginecologia e Ostetricia, Università Cattolica, Roma, Italia
| | | | | | | | | | | |
Collapse
|
33
|
Corrado F, Noccioli G, Tocci A, Urbanetti S. [Surgical delivery: comparison of two 5-year periods]. Minerva Ginecol 1994; 46:265-9. [PMID: 7936376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Operative delivery prevalence is considered in two periods: 1980-1985 and 1986-1990. Reduced prevalence of repeated cesarean section is reported for the second period as opposed to the first one. A larger prevalence of cesarean sections for anomalous presentation (breech presentation included), fetal distress. EPH gestosis, abruptio placentae is reported in the second half of '80's. Vacuum Extractor applications are reduced in the second period compared to the first one for with concern secondary uterine hypokinesia; larger V.E. applications are reported in the second period for fetal distress in the second stage of labor. Relatively rare forceps applications in both periods.
Collapse
Affiliation(s)
- F Corrado
- Divisione di Ostetricia e Ginecologia, Ospedale San Giovanni Evangelista, USSL n. 26, Tivoli
| | | | | | | |
Collapse
|
34
|
Tocci A, Rezzoug F, Aitouche A, Touraine JL. Comparison of fresh, cryopreserved and cultured haematopoietic stem cells from fetal liver. Bone Marrow Transplant 1994; 13:641-8. [PMID: 7914448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The cryopreservation and long-term culture of fetal liver (FL) cells may offer a ready source of haematopoietic stem cells (HSC). To compare these two techniques, an H-2-incompatible murine model was used, in conditions close to those of stem cell transplantation in humans. After cryopreservation, the recovery of colony-forming unit-culture (CFU-C) and of 14-day colony-forming unit-spleen (CFU-S) was 55.5% and 23%, respectively, compared with fresh cells. The rate of engraftment of donor cells was very high in mice reconstituted with either cryopreserved or fresh cells and the resulting chimerism was virtually complete in both cases. Functionally, both groups showed a significant humoral response to sheep red blood cells. Chimeric mice obtained by injection of cryopreserved cells were able to reject third-party SJL mouse (H-2s) skin grafts (11.4 +/- 1.6 days); at the same time, they specifically tolerated skin grafts from BDF1 (H-2b x H-2d) donor mice, indicating that cryopreserved FL cells could induce both tolerance to donor antigens and restore normal immunological responses to third-party alloantigens. Following 4-week cultures, consistent losses in the total number of CFU-C and CFU-S (2.5% and 8.6% yield, respectively) were observed. Cultured FL failed to protect the animals from the lethal effects of irradiation, due to insufficient reconstitution. These results favour the possible use of cryopreserved FL in clinical settings. At present, however, techniques to improve FL cultures and their efficiency for in vivo reconstitution are required.
Collapse
Affiliation(s)
- A Tocci
- Transplantation and Clinical Immunology Unit, Hôpital Edouard Herriot, Lyon, France
| | | | | | | |
Collapse
|
35
|
Tocci A, Noccioli G, Doninelli M, De Filippi M. [A case of intestinal obstruction in pregnancy]. Minerva Ginecol 1994; 46:53-5. [PMID: 8177465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Intestinal obstruction during pregnancy is a rare and dangerous complication. The causes of its occurrence are previous operations ad inflammation and one of their results: adhesions. Symptoms of intestinal obstruction (nausea, vomiting, constipation) rarely occur simultaneously and often accompany normal pregnancy, hampering diagnosis. Abdominal X-ray often represents the only complementary investigation diriment for diagnosis. A case of intestinal obstruction at 36 weeks gestation is reported to emphasize diagnostic difficulties of this rare pregnancy complication.
Collapse
Affiliation(s)
- A Tocci
- Divisione di Ostetricia e Ginecologia, Ospedale Civile, Tivoli, Roma
| | | | | | | |
Collapse
|
36
|
Luoni M, Croci E, De Paoli A, Fava S, Grimi E, Tocci A, Tosi A, Cassi E. Retroperitoneal hemorrhage following bone marrow biopsy. Haematologica 1994; 79:70-2. [PMID: 15378952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/30/2023] Open
Abstract
We report the case of an elderly woman with polycythemia vera submitted to bone marrow biopsy who developed retroperitoneal hemorrhage as a result of direct penetration of the needle through the iliac crest, with damage to the iliolumbar artery, the first branch of the hypogastric artery.
Collapse
Affiliation(s)
- M Luoni
- II Division of Medicine, General Hospital, Legnano, Italy
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Corrado F, Noccioli G, Tocci A, Urbanetti S. [Evaluation of indications for cesarean section. Comparison of two decades. Preliminary results]. Minerva Ginecol 1993; 45:527-30. [PMID: 8121599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We have retrospectively analysed the incidence of cesarean section during the periods 1970-79 and 1981-90 and the evolution, if any, of the principal indication over time. The average incidence of cesarean section was 9.01% in the seventies and 11.63% in the eighties: the difference was statistically significant. Four classes of indication show significant differences between the periods considered: previous cesarean, feto-pelvic disproportion, anomalous presentation, gestosis. An evolution of cesarean section indications is shown: minus parity, better health, sanitary and environmental conditions, better physiopathological and clinical knowledge of pregnancy complication and labor seem to be causes of that evolution.
Collapse
Affiliation(s)
- F Corrado
- Divisione di Ostetricia e Ginecologia, USL RM/26-Ospedale di Tivoli, Roma
| | | | | | | |
Collapse
|
38
|
Noia G, De Santis M, Tocci A, Maussier ML, D'Errico G, Bianchi A, Romagnoli C, Masini L, Caruso A, Mancuso S. Early prenatal diagnosis and therapy of fetal hypothyroid goiter. Fetal Diagn Ther 1992; 7:138-43. [PMID: 1503649 DOI: 10.1159/000263661] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
We report a case of early diagnosis of iodide-induced fetal hypothyroidism at 22 weeks of gestation, confirmed at 29 weeks by cordocentesis and successfully treated intra-amniotically. The ultrasonographic feature was the presence of two echogenic masses in the fetal neck; polyhydramnios was absent. Mild hypothyroidism was diagnosed based on fetal serum obtained by percutaneous umbilical blood sampling at 29 weeks of gestation. The persistence of fetal hypothyroidism in spite of maternal thyroid improvement was confirmed by a second cordocentesis at 35 weeks of gestation, and a single injection of intra-amniotic levothyroxine (250 micrograms) was performed. The serial ultrasonographic examinations showed disappearance of the fetal goiter. A healthy female baby (3,630 g) was delivered at term. At birth, the thyroid gland was not enlarged, and neonatal thyroid hormones were within the normal range. This case suggests that cordocentesis is a reliable method to assess the fetal thyroid status; moreover a single injection of intra-amniotic thyroxine was effective in treating fetal hypothyroid goiter.
Collapse
Affiliation(s)
- G Noia
- Department of Obstetrics and Gynecology, Catholic University, Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|